Annual Revenue
$116.88 M
-$3.36 M-2.79%
31 December 2023
Summary:
Rigel Pharmaceuticals annual revenue is currently $116.88 million, with the most recent change of -$3.36 million (-2.79%) on 31 December 2023. During the last 3 years, it has risen by +$8.26 million (+7.61%). RIGL annual revenue is now -21.68% below its all-time high of $149.24 million, reached on 31 December 2021.RIGL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$55.31 M
+$18.47 M+50.12%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly revenue is currently $55.31 million, with the most recent change of +$18.47 million (+50.12%) on 30 September 2024. Over the past year, it has increased by +$27.17 million (+96.58%). RIGL quarterly revenue is now -31.73% below its all-time high of $81.02 million, reached on 31 March 2021.RIGL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$157.47 M
+$27.17 M+20.85%
30 September 2024
Summary:
Rigel Pharmaceuticals TTM revenue is currently $157.47 million, with the most recent change of +$27.17 million (+20.85%) on 30 September 2024. Over the past year, it has increased by +$25.11 million (+18.97%). RIGL TTM revenue is now at all-time high.RIGL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.8% | +96.6% | +19.0% |
| 3 y3 years | +7.6% | +156.7% | +6.9% |
| 5 y5 years | +162.6% | +165.2% | +92.6% |
RIGL Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -21.7% | +7.6% | at high | +230.5% | at high | +85.4% |
| 5 y | 5 years | -21.7% | +162.6% | -31.7% | +259.1% | at high | +165.6% |
| alltime | all time | -21.7% | >+9999.0% | -31.7% | >+9999.0% | at high | >+9999.0% |
Rigel Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $55.31 M(+50.1%) | $157.47 M(+20.9%) |
| June 2024 | - | $36.84 M(+24.7%) | $130.30 M(+8.3%) |
| Mar 2024 | - | $29.53 M(-17.5%) | $120.35 M(+3.0%) |
| Dec 2023 | $116.88 M(-2.8%) | $35.79 M(+27.2%) | $116.88 M(-11.7%) |
| Sept 2023 | - | $28.13 M(+4.6%) | $132.37 M(+4.5%) |
| June 2023 | - | $26.89 M(+3.1%) | $126.64 M(-2.3%) |
| Mar 2023 | - | $26.07 M(-49.2%) | $129.58 M(+7.8%) |
| Dec 2022 | $120.24 M(-19.4%) | $51.28 M(+128.8%) | $120.24 M(+34.5%) |
| Sept 2022 | - | $22.41 M(-24.8%) | $89.37 M(+1.0%) |
| June 2022 | - | $29.82 M(+78.2%) | $88.51 M(+4.2%) |
| Mar 2022 | - | $16.73 M(-18.0%) | $84.95 M(-43.1%) |
| Dec 2021 | $149.24 M(+37.4%) | $20.41 M(-5.3%) | $149.24 M(+1.3%) |
| Sept 2021 | - | $21.54 M(-18.0%) | $147.28 M(+2.2%) |
| June 2021 | - | $26.27 M(-67.6%) | $144.12 M(+7.7%) |
| Mar 2021 | - | $81.02 M(+339.1%) | $133.88 M(+23.3%) |
| Dec 2020 | $108.62 M(+83.2%) | $18.45 M(+0.3%) | $108.62 M(+2.9%) |
| Sept 2020 | - | $18.39 M(+14.8%) | $105.57 M(-2.3%) |
| June 2020 | - | $16.02 M(-71.3%) | $108.04 M(+5.5%) |
| Mar 2020 | - | $55.76 M(+262.1%) | $102.42 M(+72.8%) |
| Dec 2019 | $59.29 M(+33.2%) | $15.40 M(-26.2%) | $59.29 M(-27.5%) |
| Sept 2019 | - | $20.86 M(+100.4%) | $81.75 M(+24.3%) |
| June 2019 | - | $10.41 M(-17.6%) | $65.75 M(+15.1%) |
| Mar 2019 | - | $12.62 M(-66.7%) | $57.13 M(+28.4%) |
| Dec 2018 | $44.51 M(+892.6%) | $37.86 M(+678.2%) | $44.51 M(+569.1%) |
| Sept 2018 | - | $4.87 M(+172.2%) | $6.65 M(+147.6%) |
| June 2018 | - | $1.79 M(+98.6%) | $2.69 M(-64.1%) |
| Dec 2017 | $4.48 M(-78.0%) | - | - |
| Sept 2017 | - | $900.00 K(-74.9%) | $7.48 M(-60.5%) |
| Mar 2017 | - | $3.58 M(+19.5%) | $18.94 M(-7.1%) |
| Dec 2016 | $20.38 M(-29.5%) | $3.00 M(-20.2%) | $20.38 M(-21.4%) |
| Sept 2016 | - | $3.76 M(-56.2%) | $25.92 M(-26.3%) |
| June 2016 | - | $8.59 M(+70.9%) | $35.16 M(+10.7%) |
| Mar 2016 | - | $5.03 M(-41.1%) | $31.75 M(+9.9%) |
| Dec 2015 | $28.89 M(+250.2%) | $8.54 M(-34.3%) | $28.89 M(+41.9%) |
| Sept 2015 | - | $13.00 M(+150.7%) | $20.36 M(+176.5%) |
| June 2015 | - | $5.18 M(+138.0%) | $7.36 M(+238.0%) |
| Mar 2015 | - | $2.18 M(-62.1%) | $2.18 M(-69.5%) |
| Dec 2014 | $8.25 M(+15.4%) | - | - |
| Dec 2013 | $7.15 M(+217.8%) | $5.75 M(+310.7%) | $7.15 M(+410.7%) |
| June 2013 | - | $1.40 M(-6.7%) | $1.40 M(-78.8%) |
| Dec 2012 | $2.25 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $1.50 M(+100.0%) | $6.61 M(+20.1%) |
| Mar 2012 | - | $750.00 K(-82.8%) | $5.50 M(+15.8%) |
| Dec 2011 | $4.75 M(-96.2%) | - | - |
| Sept 2011 | - | $4.36 M(+1002.5%) | $4.75 M(-93.5%) |
| June 2011 | - | $395.00 K(-99.5%) | $72.68 M(-42.2%) |
| Dec 2010 | $125.00 M(>+9900.0%) | - | - |
| Sept 2010 | - | $72.28 M(+46.2%) | $125.75 M(+135.2%) |
| June 2010 | - | $49.46 M(+1416.6%) | $53.47 M(+1233.0%) |
| Mar 2010 | - | $3.26 M(+334.8%) | $4.01 M(+434.8%) |
| Dec 2009 | $750.00 K(-94.0%) | $750.00 K(-90.6%) | $750.00 K(-94.0%) |
| Dec 2007 | $12.60 M(-62.4%) | $8.00 M(+309.0%) | $12.60 M(-9.1%) |
| June 2007 | - | $1.96 M(-26.0%) | $13.86 M(-47.2%) |
| Mar 2007 | - | $2.64 M(-15.5%) | $26.22 M(-21.7%) |
| Dec 2006 | $33.47 M(+102.5%) | $3.13 M(-48.9%) | $33.47 M(-8.0%) |
| Sept 2006 | - | $6.13 M(-57.2%) | $36.37 M(+8.5%) |
| June 2006 | - | $14.32 M(+44.7%) | $33.52 M(+40.8%) |
| Mar 2006 | - | $9.90 M(+64.4%) | $23.80 M(+44.0%) |
| Dec 2005 | $16.53 M(+249.2%) | $6.02 M(+83.4%) | $16.53 M(+42.4%) |
| Sept 2005 | - | $3.28 M(-28.7%) | $11.61 M(+29.2%) |
| June 2005 | - | $4.61 M(+75.9%) | $8.98 M(+53.2%) |
| Mar 2005 | - | $2.62 M(+138.0%) | $5.86 M(+23.9%) |
| Dec 2004 | $4.73 M(-57.2%) | $1.10 M(+66.9%) | $4.73 M(-17.5%) |
| Sept 2004 | - | $659.00 K(-55.7%) | $5.74 M(-20.1%) |
| June 2004 | - | $1.49 M(0.0%) | $7.18 M(-10.7%) |
| Mar 2004 | - | $1.49 M(-29.4%) | $8.04 M(-27.2%) |
| Dec 2003 | $11.05 M(-30.0%) | $2.11 M(+0.1%) | $11.05 M(-12.6%) |
| Sept 2003 | - | $2.10 M(-10.5%) | $12.65 M(-10.9%) |
| June 2003 | - | $2.35 M(-47.8%) | $14.20 M(-12.3%) |
| Mar 2003 | - | $4.50 M(+21.5%) | $16.19 M(+2.5%) |
| Dec 2002 | $15.79 M(+3.2%) | $3.70 M(+1.3%) | $15.79 M(-6.4%) |
| Sept 2002 | - | $3.65 M(-15.8%) | $16.87 M(-3.2%) |
| June 2002 | - | $4.34 M(+5.8%) | $17.42 M(+7.5%) |
| Mar 2002 | - | $4.10 M(-14.2%) | $16.21 M(+5.9%) |
| Dec 2001 | $15.30 M(+15.8%) | $4.78 M(+13.6%) | $15.30 M(+11.4%) |
| Sept 2001 | - | $4.21 M(+34.7%) | $13.73 M(+6.8%) |
| June 2001 | - | $3.12 M(-2.2%) | $12.86 M(-1.6%) |
| Mar 2001 | - | $3.19 M(-0.5%) | $13.08 M(-1.1%) |
| Dec 2000 | $13.22 M(+47.1%) | $3.21 M(-3.8%) | $13.22 M(+32.1%) |
| Sept 2000 | - | $3.34 M(0.0%) | $10.01 M(+50.0%) |
| June 2000 | - | $3.34 M(0.0%) | $6.67 M(+100.0%) |
| Mar 2000 | - | $3.34 M | $3.34 M |
| Dec 1999 | $8.98 M | - | - |
FAQ
- What is Rigel Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual revenue year-on-year change?
- What is Rigel Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly revenue year-on-year change?
- What is Rigel Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals TTM revenue year-on-year change?
What is Rigel Pharmaceuticals annual revenue?
The current annual revenue of RIGL is $116.88 M
What is the all time high annual revenue for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual revenue is $149.24 M
What is Rigel Pharmaceuticals annual revenue year-on-year change?
Over the past year, RIGL annual revenue has changed by -$3.36 M (-2.79%)
What is Rigel Pharmaceuticals quarterly revenue?
The current quarterly revenue of RIGL is $55.31 M
What is the all time high quarterly revenue for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly revenue is $81.02 M
What is Rigel Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, RIGL quarterly revenue has changed by +$27.17 M (+96.58%)
What is Rigel Pharmaceuticals TTM revenue?
The current TTM revenue of RIGL is $157.47 M
What is the all time high TTM revenue for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high TTM revenue is $157.47 M
What is Rigel Pharmaceuticals TTM revenue year-on-year change?
Over the past year, RIGL TTM revenue has changed by +$25.11 M (+18.97%)